Alternative honey & biosynthetic honey

01Overview and value chain

Markers: [EC: EU Novel Food Regulation (EC 2015/2283) | OECD: Food Systems | Regulator: FDA (USA), EFSA (EU), NMPA (China)]

Biosynthetic honey is built ex vivo: purified recombinant bee enzymes convert plant sugars under tightly controlled conditions into a product chemically and physically identical to natural honey, but 100% vegan and free of Clostridium botulinum spores, antibiotic residues and pesticides. The 2026 segment is a FoodTech response to two crises — colony-collapse disorder driven by neonicotinoids and climate change, and chronic honey adulteration (rice-syrup dilution, heavy-metal and pesticide contamination of imports). Engineered Pichia pastoris yeast secrete the key bee enzymes — invertase (beta-fructofuranosidase), glucose oxidase and alpha-amylase — which are recovered by ultrafiltration and chromatography, then blended with refined plant sugars and trace plant metabolites (monoterpenes, polyphenols) to reconstruct specific varietal profiles (linden, buckwheat, acacia).

The key directions of alternative honey & biosynthetic honey are:

1. Recombinant bee-enzyme expression (Recombinant Bee Enzymes): industrial Pichia pastoris fermentation secreting invertase, glucose oxidase and alpha-amylase encoded from the Apis mellifera genome.
2. Phytochemical flavour reconstruction (Phytochemical Reconstruction): integration of monoterpenes (linalool, geraniol) and polyphenols (caffeic acid, quercetin) to reproduce the taste of monofloral honey varieties.
3. Biocatalytic maturation (Biocatalytic Maturation): purified invertase splits sucrose into an equimolar glucose/fructose mix while glucose oxidase generates gluconic acid and trace hydrogen peroxide, giving antibacterial activity and the characteristic mild acidity (pH 3.5–4.5).
4. Vegan & hypoallergenic B2B honey (Vegan B2B Honey): a product fully cleared of C. botulinum spores and antibiotic residues, positioned as infant-safe and vegan/halal for confectionery, bakery and cosmetics brands.

Sectoral value chain

[Bee-enzyme expression in Pichia] ──> [Enzyme downstream (UF + chromatography)]
           │                                       │
    (methanol-induced secretion)          (50 kDa cutoff, ion-exchange)
                                                   │
                                                   ▼
[B2B filling & distribution] <── [Pasteurization & deaeration] <── [Enzymatic maturation]
                                          │
                                  (sugar + phytochemical blend)

Value chain levels

Cross-cutting technologies of the sector:

• Enzymatic nectar synthesis (Enzymatic Nectar Synthesis): purified recombinant invertase cleaves plant sucrose into an equimolar glucose/fructose mix, mirroring honey-ripening in the bee’s honey stomach.
• Biocatalytic gluconic-acid generation (Biocatalytic Gluconic Acid Generation): recombinant glucose oxidase partially oxidizes glucose to gluconic acid and trace hydrogen peroxide, delivering antibacterial activity and the characteristic mild acidity (pH 3.5–4.5).
• DNA barcoding & LC-MS authenticity (DNA-Barcoding Authenticity): molecular verification methods that confirm the purity and identity of biosynthetic honey against natural reference standards.

02US

The US leads commercialization of biosynthetic honey, with MeliBio the first company to bring bee-free honey to industrial scale and the FDA clearing it as a safe food ingredient.

MeliBio Mellody commercialization, FDA clearance, vegan & halal demand

• MeliBio (Mellody): the world’s first industrial-scale bee-free honey brand, with B2B supply to vegan confectionery and cosmetics makers and retail roll-outs in Europe with Aldi.
• FDA clearance: the FDA classifies biosynthetic honey as a safe food ingredient, clearing the path for conventional retail; demand is driven by vegan and halal markets and by brands seeking to exit insect-exploitation-linked ingredients.
• USDA pollinator R&D: the USDA-ARS Honey Bee Research Lab underpins the sector with pollinator biology research and analytical tests that distinguish bio- from conventional honey.

03CN

China is the world’s largest traditional-honey producer and is actively building biosynthetic-substitution capacity, with R&D centres in Zhejiang focused on high-speed enzymatic syrup blending and low-cost enzyme production.

Zhejiang R&D, large-fermenter enzyme cost reduction, DNA-barcoding purity

• Zhejiang University R&D: research groups specialize in the enzymatic kinetics of bee amylases and invertases and on scaling protein expression in methylotrophic yeast.
• Large-fermenter cost reduction: Chinese B2B suppliers target lower enzyme production cost using high-capacity industrial fermenters and automated glucose-fructose syrup blending lines.
• DNA barcoding & mass spectrometry: Chinese labs develop DNA-barcoding and LC-MS methods to certify the high purity and identity of biosynthetic honey against natural analogues.

04EU

The European Union approaches the sector through strict Novel Food regulation, with EFSA evaluating recombinant bee enzymes for allergenic potential and German/Austrian startups reconstructing monofloral profiles.

EFSA Novel Food, monofloral profile reconstruction, residue-free positioning

• EFSA Novel Food scrutiny: the EFSA panel assesses recombinant bee enzymes for allergenic potential before clearing biosynthetic honey for the EU market under the Novel Food regulation.
• Monofloral profile reconstruction: German and Austrian startups (e.g. Fooditive in the wider EU fermentation cluster) work on reconstructing unique monofloral profiles such as alpine wildflower honey via fine phytochemical extraction.
• Residue-free positioning: European consumers value biosynthetic honey for the absence of glyphosate and neonicotinoid residues frequently found in imported natural honey, reinforcing a clean-label, pollinator-friendly proposition.

05Leading companies and research institutes

06Tech stack and innovations

The molecular stack pairs an Apis mellifera enzyme set expressed in Pichia with a vacuum-blended sugar and phytochemical base, instrumented for dry-solids and viscosity control.

1. Expression strains & enzyme stack (Molecular Stack):
   • Pichia pastoris strain X-33 carries the Apis mellifera invertase gene; the enzyme stack adds recombinant glucose oxidase (from Aspergillus niger) and alpha-amylase, each methanol-induced-secreted in a 30 m³ fermenter.
   • gluconic-acid accumulation by glucose oxidase is oxygen-limited: the rate tracks the dissolved-oxygen partial pressure in the maturation reactor, so aeration is tuned to hold pH at the 3.8 target without overshoot.
2. Vacuum blending & downstream (Process Stack):
   • vacuum Stephan homogenizer reactors blend the sugar base (fructose 40%, glucose 35%, maltose 5%) with trace polyphenols and terpenes under deaeration.
   • downstream uses 50 kDa hollow-fibre ultrafiltration to concentrate the enzyme, followed by macroporous ion-exchange chromatography on Cytiva ÄKTA flux systems.
3. Analytics & viscosity control (Analytical Stack):
   • Anton Paar refractometers track dry-solids content to the 82–84% target and HPLC-RI systems verify the saccharide profile.
   • Brookfield rotational viscometers hold the honey within the viscosity window that matches natural honey mouthfeel.

07Value chains and production pipelines

Industrial pipeline of biosynthetic honey by Pichia enzyme expression and enzymatic maturation (ISO 22000 / GMP)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Pichia fermentation    │ ───> │ 2. Enzyme downstream      │
│    and invertase secretion│      │    (UF + chromatography)  │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Enzymatic maturation   │ <─── │ 3. Sugar & phytochemical  │
│    (35 °C, vacuum)        │      │    blending               │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Deaeration &           │ ───> │ 6. IBC filling & sterile  │
│    pasteurization         │      │    B2B sampling           │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Pichia fermentation and invertase secretion

Engineered Pichia pastoris is cultured in a 30 m³ fermenter with methanol as the inducer, secreting recombinant bee invertase into the broth over the induction phase.

Stage 2: Enzyme downstream recovery

The culture broth is passed through 50 kDa-cutoff ultrafiltration cartridges to concentrate the enzyme, then polished on macroporous ion-exchange resins to yield a purified enzyme concentrate.

Stage 3: Sugar and phytochemical blending

In a vacuum mixer, an aqueous solution of high-purity fructose (40%), glucose (35%) and maltose (5%) is blended with trace plant polyphenols (caffeic acid, quercetin) and aromatic terpenes (linalool, geraniol) to set the varietal profile.

Stage 4: Enzymatic maturation (biotransformation)

The purified enzyme cocktail (invertase + glucose oxidase) is dosed into the blend; the reaction runs at 35 °C for 48 hours under vacuum, dewatering to a final 82–84% dry solids, while glucose oxidase generates gluconic acid and drops the pH to 3.8.

Stage 5: Deaeration and pasteurization

The matured honey is deaerated to remove entrained air bubbles and flash-pasteurized to fix the viscosity and microbiology before filling.

Stage 6: IBC filling and sterile B2B sampling

The finished honey is filled into 1000 L IBC totes fitted with sterile Swagelok sampling caps, preventing contamination by wild yeast during B2B storage and shipment to confectionery, bakery and cosmetics buyers.